CD8A and leukemia: Mechanistically, Tnfrsf4 antibody treatment significantly increased the CD8/Treg ratio in BM without depleting/reducing Treg numbers (Figure 7, F and G), which resulted in reduced leukemia and reduced numbers of BM LSCs (Figure 7, H–J).